Trial Profile
Safety and efficacy of NeuroEPO in patients with stroke. Phase I-II
Status:
Not yet recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 14 Oct 2020
Price :
$35
*
At a glance
- Drugs Epoetin alfa (Primary)
- Indications Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms IICRD-EC153; NeuroEPO-Stroke
- 21 Jan 2016 New trial record